Deerfield Management Company »

Schweitzer-Mauduit International shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Schweitzer-Mauduit International (MATV) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Schweitzer-Mauduit International

Tip: Access up to 7 years of quarterly data

All positions including Schweitzer-Mauduit International held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Schweitzer-Mauduit International by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $359k 23k 15.31

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Schweitzer-Mauduit International

Vanguard Group
Allspring Global Investments Holdings
Boundary Creek Advisors
Wellington Management Company
Dimensional Fund Advisors
Goldman Sachs Group
Vaughan Nelson Investment Management
Citadel Advisors
Charles Schwab Investment Management
Royce & Associates
Russell Investments
Walleye Trading
Invenomic Capital Management
Mirae Asset Global Investments
Bank of New York Mellon

View all funds holding Schweitzer-Mauduit International